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to PE only in 4 (0.6%) patients, and other causes included septice-
mia and acute myocardial infarction.
Discussion
In our chart review we collected data on almost 700 patients under-
going chest surgery for malignant lung disease, and almost 90% of
these patients attended at least 1 follow-up visit. Venous thrombo-
embolic events within 1 month after surgical intervention were
uncommon in these patients. Incidence of VTE was lower than pre-
viously reported. In a previous study on 77 patients undergoing pul-
monary resection,2 20 (26%) had a venous thromboembolic event
(15 deep vein thromboses and 5 PEs) during hospitalization, and
in a retrospective study on 1735 patients who underwent lung resec-
tion,3 PE was a common fatal postoperative complication, account-
ing for 15.2% of postresectional deaths. However, because these
studies were carried out between 1975 and 1993, antithrombotic
prophylaxis with heparin was rarely used in these patients.
Finally, in a small recent study carried out in 50 patients under-
going lung surgery for cancer,4 PE was detected by means of multi-
slice computed tomographic analysis in 7 (14%) patients. However,
only 2 of these patients were symptomatic, and the clinical relevance
of this complication is undefined.
In conclusion, the results of our study suggest that symptomatic
and fatal PEs are uncommon complications in these patients. Un-
fractionated heparin and low-molecular-weight heparin seem to be
equally effective in reducing venous thromboembolic events also
in patients with metastatic disease. Large prospective studies are
warranted to confirm our results.
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TABLE 1. Baseline characteristics
Total patient no. 690
Age, y (range) 66.7 (23–90)
Male sex, n (%) 418 (60.6)
History of cardiovascular
disease
155 (22.5%)
Antithrombotic prophylaxis,
n (%)
Postoperative UFH, 464 (67.2)
Postoperative LMWH, 153 (22.2)
Preoperative LMWH or UFH, 52 (7.5)
Bridging therapy, 5 (0.7)
No prophylaxis, 16 (2.3)
Type of cancer, n (%) Primary lung cancer, 507 (73.5)
Adenocarcinoma, 51.8%
Epidermoid, 28.6%
Anaplastic, 8.0%
Other, 11.6%
Secondary lung cancer, 183 (26.5)
Type of operation, n (%) Pneumectomy, 93 (13.5)
Lobectomy or wedge resection,
597 (86.5)
UFH, Unfractionated heparin; LMWH, low-molecular-weight heparin.
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racheoesophageal fistula (TEF) is an uncommon but dev-
astating complication of prolonged intubation. Pressure
exerted from the cuff of an endotracheal tube against
a rigid nasogastric tube causes tissue necrosis and break-
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nia. Urgent repair of the fistula with tissue interposition is warranted,
although this can be challenging in the ventilated patient because of
the need for continued positive pressure ventilation and the paucity
of healthy, local tissue to fashion the repair. The present study is
a case report of a 65-year-old woman in whom a large TEF devel-
oped after bilobectomy and who was successfully treated with Allo-
Derm (LifeCell Corporation, Branchburg, NJ), a commercially
available biologic tissue. In this case, AlloDerm was used as a tissue
scaffold to reconstruct the defect in the trachea to serve and enhance
the integrity of the repair.2,3
Clinical Summary
A 65-year-old woman underwent right middle and lower lobectomy
for non–small cell lung carcinoma at an outside hospital. Her post-
operative course was marked by adult respiratory distress syndrome
and prolonged mechanical ventilation that required tracheostomy.ch 2008
Brief CommunicationsFigure 1. A, Large tracheal defect ex-
posing the tracheostomy tube. B, Esoph-
ageal defect and nasogastric tube.
Figure 2. A, Computed tomographic im-
age of a large TEF. B, Follow-up com-
puted tomographic image shows intact
tracheal repair with AlloDerm (LifeCell
Corporation, Branchburg, NJ) graft.
There is no evidence of recurrence of
TEF. TEF, tracheoesophageal fistula.Six weeks post-tracheostomy, recurrent pneumonia and sepsis de-
veloped in the patient. Subsequently, the patient underwent bron-
choscopy and was diagnosed with TEF. She was transferred to the
Cleveland Clinic Foundation for management.
In the operating room, fiberoptic bronchoscopy was performed
transnasally and through the patient’s tracheal stoma. A 4-cm defect
involved the entire width of the membranous airway directly poste-
rior to the stoma. The nasogastric tube was clearly visible along this
length and confirmed the diagnosis of TEF. The region of the fistula
was 3 tracheal rings distal to the cricoid cartilage on the airway side
and 15 cm from the gums on the esophageal side. An extended
length tracheostomy was reinserted.
Given the size of the TEF, primary repair of the trachea was not
possible. We elected to use AlloDerm to reconstruct the membra-
nous trachea, close the esophageal defect primarily, and interpose
a muscle flap. The airway and esophagus were approached through
an oblique left neck incision anterior to the border of the sternoclei-
domastoid muscle. The esophagus was dissected out, encircled, and
separated from the airway. The entire tracheal and esophageal
defects were carefully delineated (Figure 1). The esophagus was
repaired using interrupted 3-0 Vicryl sutures. A 4 3 2.5-cm
AlloDerm patch was then parachuted down to reconstruct the mem-
branous trachea and secured to the edges of the cartilaginous airway
using 3-0 Vicryl sutures. A pectoralis major muscle flap was then
mobilized and interposed between the 2 repairs. Postoperatively,
the patient had an uneventful recovery and was weaned from the
ventilator. On the fifth postoperative day, a flexible bronchoscopy
was performed through the stoma. This revealed an intact, well-ap-
proximated AlloDerm graft with no evidence of airway narrowing.The Journal of ThoThe patient was discharged on the 18th postoperative day and
decannulated 7 weeks postoperatively in the clinic. Currently, she is
tolerating a normal oral diet and doing well at 4 months’ follow-up.
A follow-up computed tomography scan was performed that
demonstrated a widely patent trachea with no residual tracheal
defect or fistula (Figure 2).
Discussion
Secure closure of postintubationTEF is a challenge because of global
patient debilitation, inadequacy of local tissue for reconstruction, and
an inflamed, infected operative field.4 AlloDerm, an acellular dermal
matrix derived from donated human skin tissue, has been used in
a broad range of tissue reconstruction. Its rigidity and substantial
ability to resist infection allowed this repair of a large TEF. Tissue
ingrowth appears to prevent shrinkage and stricture. AlloDerm is
a useful tool for complex airway reconstructions when options are
limited.
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